Renaissance Technologies - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 298 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q4 2022$3,590
-99.7%
304,000
+451.7%
0.01%
+150.0%
Q3 2022$1,157,000
-60.8%
55,100
-42.0%
0.00%
-33.3%
Q2 2022$2,949,000
-79.9%
95,000
-73.5%
0.00%
-82.4%
Q1 2022$14,699,000
+164.2%
358,000
+476.5%
0.02%
+183.3%
Q4 2020$5,564,000
+22.1%
62,100
+40.8%
0.01%
+20.0%
Q3 2020$4,557,000
-85.0%
44,104
-88.5%
0.01%
-80.8%
Q2 2020$30,416,000
-15.6%
384,624
-38.3%
0.03%
-25.7%
Q1 2020$36,047,000
-12.6%
623,001
-18.5%
0.04%
+9.4%
Q4 2019$41,223,000
-19.9%
764,101
-22.4%
0.03%
-27.3%
Q3 2019$51,460,000
-21.1%
984,311
-27.1%
0.04%
-22.8%
Q2 2019$65,243,000
-34.7%
1,350,511
-31.7%
0.06%
-37.4%
Q1 2019$99,949,000
+5.6%
1,978,402
+24.0%
0.09%
-12.5%
Q4 2018$94,612,000
-23.2%
1,596,011
-14.7%
0.10%
-18.1%
Q3 2018$123,188,000
-39.2%
1,871,311
-52.4%
0.13%
+14.4%
Q2 2018$202,684,000
+106.1%
3,934,422
+110.6%
0.11%
+2.8%
Q1 2018$98,346,000
+33.5%
1,867,911
+17.9%
0.11%
+33.3%
Q4 2017$73,651,000
+58.0%
1,584,911
+37.5%
0.08%
+47.3%
Q3 2017$46,623,000
+67.6%
1,152,611
+40.5%
0.06%
+52.8%
Q2 2017$27,820,000
+36.3%
820,411
+16.7%
0.04%
+24.1%
Q1 2017$20,407,000
-29.7%
702,711
-20.5%
0.03%
-37.0%
Q4 2016$29,015,000
-21.9%
883,511
-25.0%
0.05%
-30.3%
Q3 2016$37,146,000
+3.7%
1,178,111
-7.5%
0.07%
-2.9%
Q2 2016$35,831,000
-11.4%
1,274,211
+14.5%
0.07%
-11.7%
Q1 2016$40,451,000
+6.2%
1,112,811
+16.9%
0.08%
-7.2%
Q4 2015$38,074,000
+72.6%
951,611
+22.9%
0.08%
+56.6%
Q3 2015$22,057,000
-0.3%
774,211
+15.3%
0.05%
+6.0%
Q2 2015$22,126,000
+31.1%
671,511
+14.4%
0.05%
+38.9%
Q1 2015$16,877,000
+21.3%
586,811
+14.8%
0.04%
+5.9%
Q4 2014$13,918,000
+21.1%
511,111
-5.2%
0.03%
+9.7%
Q3 2014$11,495,000
-15.8%
539,411
-11.2%
0.03%
-3.1%
Q2 2014$13,645,000
-29.2%
607,511
-20.4%
0.03%
-30.4%
Q1 2014$19,278,000
+48.8%
762,898
+35.4%
0.05%
+48.4%
Q4 2013$12,957,000
+13.8%
563,611
-5.7%
0.03%
+10.7%
Q3 2013$11,383,000
+9.1%
597,511
-17.4%
0.03%
+3.7%
Q2 2013$10,437,000723,8110.03%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2020
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 1,031,859$59,703,0003.40%
Laurus Investment Counsel Inc. 74,169$4,291,0003.10%
Hillcrest Asset Management LLC 220,660$12,767,0003.07%
RICE HALL JAMES & ASSOCIATES, LLC 765,202$44,275,0002.47%
Tygh Capital Management, Inc. 142,732$8,258,0001.85%
EARNEST PARTNERS LLC 2,782,776$161,011,0001.81%
Pier Capital, LLC 93,603$5,416,0001.20%
Portolan Capital Management 131,659$7,618,0001.14%
Phocas Financial Corp. 92,759$5,367,0001.08%
Consolidated Investment Group LLC 37,000$2,141,0000.94%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders